Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small cell lung cancer: A phase II, open-label, multicenter, randomized study. This is an ASCO Meeting Abstract from the 2013 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results